The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats
Open accessAbstract
The effects of an oral daily dose (10 mg kg−1) of the flavonoid quercetin for 5 weeks in spontaneously hypertensive (SHR) and normotensive Wistar Kyoto rats (WKY) were analysed. Quercetin induced a significant reduction in systolic (−18%), diastolic (−23%) and mean (−21%) arterial blood pressure and heart rate (−12%) in SHR but not in WKY rats. The left ventricular weight index and the kidney weight index in vehicle‐treated SHR were significantly greater than in control WKY and these parameters were significantly reduced in quercetin‐treated SHR in parallel with the reduction in systolic blood pressure. Quercetin had no effect on the vasodilator responses to sodium nitroprusside or to the vasoconstrictor responses to noradrenaline or KCl but enhanced the endothelium‐dependent relaxation to acetylcholine (E max=58±5%vs 78±5%, P<0.01) in isolated aortae. The 24 h urinary isoprostane F 2α excretion and the plasma malonyldialdehyde (MDA) levels in SHR rats were increased as compared to WKY rats. However, in quercetin‐treated SHR rats both parameters were similar to those of vehicle‐treated WKY. These data demonstrate that quercetin reduces the elevated blood pressure, the cardiac and renal hypertrophy and the functional vascular changes in SHR rats without effect on WKY. These effects were associated with a reduced oxidant status due to the antioxidant properties of the drug. British Journal of Pharmacology (2001) 133, 117–124; doi:10.1038/sj.bjp.0704064
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study
Hertog, M. G. L., Feskens, E. J. M., Kromhout, D., Hertog, M. G. L., Hollman, P. C. H., Hertog, M. G. L., & Katan, M. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)92876-u · Cited by 4,341
[42] Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal
Esterbauer, H., & Cheeseman, K. H. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86134-h · Cited by 3,345
Garg, U. C., & Hassid, A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114081 · Cited by 2,155
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T. M., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,899
Hertog, M. G. L. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430040053006 · Cited by 1,853
Flavonoid intake and coronary mortality in Finland: a cohort study
Knekt, P., Jarvinen, R., Reunanen, A., & Maatela, J. (1996) · BMJ · doi:10.1136/bmj.312.7029.478 · Cited by 1,267
Hertog, M. G. L., Hollman, P. C. H., Katan, M. B., & Kromhout, D. (1993) · Nutrition and Cancer · doi:10.1080/01635589309514267 · Cited by 1,216
Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man
Hollman, P. C. H., van Trijp, J. M. P., Buysman, M. N. C. P., v.d. Gaag, M. S., Mengelers, M. J. B., de Vries, J. H. M., & Katan, M. B. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01367-7 · Cited by 782
Frohlich, E. D., Apstein, C., Chobanian, A. V., Devereux, R. B., Dustan, H. P., Dzau, V., Fauad-Tarazi, F., Horan, M. J., Marcus, M., Massie, B., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210013271406 · Cited by 782
Does superoxide underlie the pathogenesis of hypertension?
Nakazono, K., Watanabe, N., Matsuno, K., Sasaki, J., Sato, T., & Inoue, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10045 · Cited by 747
Flavonoids in Health and Disease
Rice-Evans, C., & Packer, L. (2003) · CRC Press eBooks · doi:10.1201/9780367803681 · Cited by 690
Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression.
Rao, G. N., & Berk, B. C. (1992) · Circulation Research · doi:10.1161/01.res.70.3.593 · Cited by 649
Small artery structure in hypertension. Dual processes of remodeling and growth.
Heagerty, A. M., Aalkjaer, C., Bund, S. J., Korsgaard, N., & Mulvany, M. J. (1993) · Hypertension · doi:10.1161/01.hyp.21.4.391 · Cited by 645
Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties
Manach, C., Morand, C., Crespy, V., Demigné, C., Texier, O., Régérat, F., & Rémésy, C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00367-6 · Cited by 586
Rimm, E. B., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-5-199609010-00005 · Cited by 560
Flavonoids in Health and Disease
Rucker, R. B. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.5.891a · Cited by 554
Takahashi, K., Nammour, T. M., Fukunaga, M., Ebert, J., Morrow, J. D., Roberts, L. J., Hoover, R. L., & Badr, K. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115826 · Cited by 511
Schnackenberg, C. G., Welch, W. J., & Wilcox, C. S. (1998) · Hypertension · doi:10.1161/01.hyp.32.1.59 · Cited by 498
Morrow, J. D., & Roberts, L. J. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02072-1 · Cited by 443
Dietary Flavonoid Intake and Risk of Cardiovascular Disease in Postmenopausal Women
Yochum, L., Kushi, L. H., Meyer, K., & Folsom, A. R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009738 · Cited by 436
On the mechanism of antithrombotic action of flavonoids
Gryglewski, R. J., Korbut, R., Robak, J., & Świȩs, J. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90288-7 · Cited by 418
Antioxidant flavonols and coronary heart disease risk
Hertog, M. G., Feskens, E. J., & Kromhout, D. (1997) · The Lancet · doi:10.1016/s0140-6736(05)60135-3 · Cited by 371
Lacy, F., OʼConnor, D. T., & Schmid-Schönbein, G. W. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816030-00006 · Cited by 350
Suzuki, H., Swei, A., Zweifach, B. W., & Schmid-Schönbein, G. W. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.1083 · Cited by 340
Oxidative Stress and Cardiovascular Disease
(2019) · Cardiovascular Disease · doi:10.1002/9781118829875.ch9 · Cited by 330
Conquer, J. A., Maiani, G., Azzini, E., Raguzzini, A., & Holub, B. J. (1998) · The Journal of Nutrition · doi:10.1093/jn/128.3.593 · Cited by 330
Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships
Duarte, J., Vizcaíno, F. P., Utrilla, P., Jiménez, J., Tamargo, J., & Zarzuelo, A. (1993) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(93)90159-u · Cited by 309
Self-citationGrunfeld, S., Hamilton, C. A., Mesaros, S., McClain, S. W., Dominiczak, A. F., Bohr, D. F., & Malinski, T. (1995) · Hypertension · doi:10.1161/01.hyp.26.6.854 · Cited by 301
Are Free Radicals Involved in the Pathobiology of Human Essential Hypertension?
Kumar, K. V., & Das, U. N. (1993) · Free Radical Research Communications · doi:10.3109/10715769309056499 · Cited by 296
Mulvany, M. J., Baumbach, G. L., Aalkjær, C., Heagerty, A. M., Korsgaard, N., Schiffrin, E. L., & Heistad, D. D. (1996) · PubMed · Cited by 277
Vasodilator effects of quercetin in isolated rat vascular smooth muscle
Duarte, J., Pérez-Vizcaíno, F., Zarzuelo, A., Jiménez, J., & Tamargo, J. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90968-n · Cited by 262
Self-citationBioavailability, metabolism and physiological impact of 4-oxo-flavonoids
Manach, C., Regerat, F., Texier, O., Agullo, G., Demigne, C., & Remesy, C. (1996) · Nutrition Research · doi:10.1016/0271-5317(96)00032-2 · Cited by 235
Intengan, H. D., Thibault, G., Li, J.-S., & Schiffrin, E. L. (1999) · Circulation · doi:10.1161/01.cir.100.22.2267 · Cited by 217
Oxidative stress and cardiovascular disease.
Hoeschen, R. J. (1997) · PubMed · Cited by 189
Shutenko, Z., Henry, Y., Pinard, E., Seylaz, J., Potier, P., Berthet, F., Girard, P., & Sercombe, R. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00296-2 · Cited by 161
New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress
Givertz, M. M., & Colucci, W. S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90017-4 · Cited by 142
Moore, T. J., Vollmer, W. M., Appel, L. J., Sacks, F. M., Svetkey, L. P., Vogt, T. M., Conlin, P. R., Simons-Morton, D. G., Carter-Edwards, L., & Harsha, D. W. (1999) · Hypertension · doi:10.1161/01.hyp.34.3.472 · Cited by 139
Jameson, M. L., Dai, F. X., Lüscher, T. F., Skopec, J., Diederich, A., & Diederich, D. A. (1993) · Hypertension · doi:10.1161/01.hyp.21.3.280 · Cited by 97
Wy, T., Maxwell, Thomason, H., Blann, A. D., Gh, T., Waite, M., & Holder, R. L. (1994) · PubMed · Cited by 78
Potentiation of Nitric Oxide--Mediated Vasorelaxation by Xanthine Oxidase Inhibitors
Miyamoto, Y., Akaike, T., Yoshida, M., Goto, S., Horie, H., & Maeda, H. (1996) · Experimental Biology and Medicine · doi:10.3181/00379727-211-43982 · Cited by 76
Kitts, D. D., Yuan, Y., & Godin, D. V. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y98-010 · Cited by 52
Effect of Active Oxygen Species on Intimal Proliferation in Rat Aorta after Arterial Injury
Gong, K.-W., Zhu, G., Wang, L., & Tang, C. (2008) · Journal of Vascular Research · doi:10.1159/000159130 · Cited by 43
Cited by
Health effects of quercetin: From antioxidant to nutraceutical
Boots, A. W., Haenen, G. R. M. M., & Bast, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.008 · Cited by 2,121
Batiha, G. E.-S., Beshbishy, A. M., Ikram, M., Mulla, Z. S., El-Hack, M. E. A., Taha, A. E., Algammal, A. M., & Elewa, Y. H. A. (2020) · Foods · doi:10.3390/foods9030374 · Cited by 709
Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450
Hodek, P., Trefil, P., & Stiborová, M. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(01)00285-x · Cited by 649
Fruits and vegetables in the prevention of cellular oxidative damage
Prior, R. L. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.3.570s · Cited by 574
Quercetin Reduces Blood Pressure in Hypertensive Subjects1,
Edwards, R. L., Lyon, T., Litwin, S. E., Rabovsky, A., Symons, J. D., & Jalili, T. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.11.2405 · Cited by 551
Metadata
- Authors
- Duarte, J., Pérez‐Palencia, R., Vargas, F., Angeles Ocete, M., Pérez‐Vizcaino, F., Zarzuelo, A., & Tamargo, J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2001-05
- Volume
- 133
- Issue
- 1
- Pages
- 117-124
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2170465739
- Cited by
- 464
- References
- 43
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.